PRESS RELEASE published on 08/27/2024 at 07:30, 2 years 1 month ago Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies Dermapharm Holding SE reports 7.3% rise in unadjusted EBITDA to EUR 147.0 million, driven by organic growth in branded pharmaceuticals segment. High-revenue expected in H2. Full report at https://ir.dermapharm.de/en EBITDA Revenue Forecast Organic Growth Dermapharm Holding SE Branded Pharmaceuticals
BRIEF published on 08/14/2024 at 07:35, 2 years 1 month ago Croissance organique soutenue dans le secteur pharmaceutique à forte marge EBITDA Médicaments Revenu Dermapharm Premier Semestre 2024
BRIEF published on 08/14/2024 at 07:35, 2 years 1 month ago Sustained Organic Growth in High-Margin Pharmaceutical Business EBITDA Revenue Pharmaceuticals H1 2024 Dermapharm
PRESS RELEASE published on 08/14/2024 at 07:30, 2 years 1 month ago Sustained organic growth in high-margin existing branded pharmaceutical business Dermapharm Holding SE reports sustained organic growth in high-margin existing branded pharmaceutical business, with year-on-year drop in revenue and EBITDA in first half of 2024 Financial Results 2024 Outlook Organic Growth Dermapharm Holding SE Branded Pharmaceuticals
BRIEF published on 06/27/2024 at 18:20, 2 years 3 months ago Dermapharm Holding SE : l'Assemblée générale annuelle décide de distribuer un dividende de 0,88 EUR par action Dividende Assemblée Générale Annuelle Perspectives Financières Dermapharm
BRIEF published on 06/27/2024 at 18:20, 2 years 3 months ago Dermapharm Holding SE: Annual General Meeting Resolves Dividend Distribution of EUR 0.88 Per Share Annual General Meeting Dividend Financial Outlook Dermapharm
PRESS RELEASE published on 06/27/2024 at 18:15, 2 years 3 months ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share Dermapharm Holding SE's Annual General Meeting approves EUR 0.88 per share dividend distribution for 2024. Board actions confirmed. Outlook and acquisitions strategies highlighted Annual General Meeting Acquisitions Outlook Dividend Distribution Dermapharm Holding SE
BRIEF published on 05/15/2024 at 07:35, 2 years 4 months ago Dermapharm Holding SE annonce une baisse de son chiffre d'affaires au premier trimestre 2024 dans un contexte de forte croissance des produits pharmaceutiques de marque Résultats Financiers Croissance Organique Résilience Du Marché Produits De Santé Produits Pharmaceutiques De Marque
BRIEF published on 05/15/2024 at 07:35, 2 years 4 months ago Dermapharm Holding SE Reports Decline in Q1 2024 Revenue Amidst Strong Branded Pharmaceuticals Growth Financial Results Organic Growth Market Resilience Healthcare Products Branded Pharmaceuticals
PRESS RELEASE published on 05/15/2024 at 07:30, 2 years 4 months ago Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy Dermapharm Holding SE reports strong organic growth in core markets with resilient corporate strategy in Q1 2024 Organic Growth Q1 2024 Core Markets Dermapharm Holding SE Resilient Strategy
Published on 10/12/2026 at 22:01, 5 hours 5 minutes ago Fermi Announces Third Quarter 2026 Earnings Release and Call Date
Published on 10/12/2026 at 15:00, 12 hours 6 minutes ago Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 14 hours 6 minutes ago U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 2 days 22 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 3 days 1 hour ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/12/2026 at 20:30, 6 hours 36 minutes ago Correction of a release from 29.09.2026 18:15 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:30, 6 hours 36 minutes ago Correction of a release from 02.10.2026 14:59 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:05, 7 hours 1 minute ago SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
Published on 10/12/2026 at 19:10, 7 hours 56 minutes ago Cell Impact announces acceleration of previously communicated order from US customer
Published on 10/12/2026 at 19:00, 8 hours 6 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 5 octobre 2026 au 9 octobre 2026
Published on 10/12/2026 at 17:59, 9 hours 7 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:59, 9 hours 7 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 7 au 9 octobre 2026
Published on 10/12/2026 at 17:45, 9 hours 21 minutes ago Déclaration des transactions sur actions propres réalisées du 05/10/2026 au 11/10/2026
Published on 10/12/2026 at 17:45, 9 hours 21 minutes ago Déclaration hebdomadaire de rachat d'actions
